<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Dev Biol</journal-id><journal-title>BMC Developmental Biology</journal-title><issn pub-type="epub">1471-213X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-213X-9-26</article-id><article-id pub-id-type="pmid">19356224</article-id><article-id pub-id-type="doi">10.1186/1471-213X-9-26</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Adenomatous polyposis coli-mediated control of &#x003b2;-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursors</article-title></title-group><contrib-group><contrib id="A1" equal-contrib="yes" contrib-type="author"><name><surname>Miclea</surname><given-names>Razvan L</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>r.l.miclea@lumc.nl</email></contrib><contrib id="A2" equal-contrib="yes" corresp="yes" contrib-type="author"><name><surname>Karperien</surname><given-names>Marcel</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>h.b.j.karperien@tnw.utwente.nl</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Bosch</surname><given-names>Cathy AJ</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>c.a.j.bosch@lumc.nl</email></contrib><contrib id="A4" contrib-type="author"><name><surname>van der Horst</surname><given-names>Geertje</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>g.van_der_horst@lumc.nl</email></contrib><contrib id="A5" contrib-type="author"><name><surname>van der Valk</surname><given-names>Martin A</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>ma.vd.valk@nki.nl</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Kobayashi</surname><given-names>Tatsuya</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>kobayash@HELIX.MGH.HARVARD.EDU</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Kronenberg</surname><given-names>Henry M</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>hkronenberg@partners.org</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Rawadi</surname><given-names>Georges</given-names></name><xref ref-type="aff" rid="I7">7</xref><email>georges.rawadi@glpg.com</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Ak&#x000e7;akaya</surname><given-names>Pinar</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>pinarakcakaya@gmail.com</email></contrib><contrib id="A10" contrib-type="author"><name><surname>L&#x000f6;wik</surname><given-names>Clemens WGM</given-names></name><xref ref-type="aff" rid="I8">8</xref><email>c.w.g.m.lowik@lumc.nl</email></contrib><contrib id="A11" contrib-type="author"><name><surname>Fodde</surname><given-names>Riccardo</given-names></name><xref ref-type="aff" rid="I9">9</xref><email>r.fodde@erasmusmc.nl</email></contrib><contrib id="A12" contrib-type="author"><name><surname>Wit</surname><given-names>Jan Maarten</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>j.m.wit@lumc.nl</email></contrib><contrib id="A13" contrib-type="author"><name><surname>Robanus-Maandag</surname><given-names>Els C</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>e.c.robanus@lumc.nl</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Pediatrics, Leiden University Medical Centre, Leiden, the Netherlands</aff><aff id="I2"><label>2</label>Department of Tissue Regeneration, Institute for Biomedical Technology, University of Twente, Enschede, the Netherlands</aff><aff id="I3"><label>3</label>Department of Human Genetics, LUMC, Leiden, the Netherlands</aff><aff id="I4"><label>4</label>Department of Urology, Leiden University Medical Centre, Leiden, the Netherlands</aff><aff id="I5"><label>5</label>Department of Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands</aff><aff id="I6"><label>6</label>Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA</aff><aff id="I7"><label>7</label>Galapagos, Romainville, 93230, France</aff><aff id="I8"><label>8</label>Department of Endocrinology and Metabolic Diseases, Leiden University Medical Centre, Leiden, the Netherlands</aff><aff id="I9"><label>9</label>Department of Pathology, Josephine Nefkens Institute, Erasmus Medical Centre, Rotterdam, the Netherlands</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>8</day><month>4</month><year>2009</year></pub-date><volume>9</volume><fpage>26</fpage><lpage>26</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-213X/9/26"/><history><date date-type="received"><day>4</day><month>12</month><year>2008</year></date><date date-type="accepted"><day>8</day><month>4</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Miclea et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Miclea et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Miclea L Razvan r.l.miclea@lumc.nl </dc:author><dc:title> Adenomatous polyposis coli-mediated control of &#x003b2;-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursors </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>BMC Developmental Biology 9(1): 26-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-213X(2009)9:1&#x0003c;26&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-213X</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>During skeletogenesis, protein levels of &#x003b2;-catenin in the canonical Wnt signaling pathway determine lineage commitment of skeletal precursor cells to osteoblasts and chondrocytes. Adenomatous polyposis coli (Apc) is a key controller of &#x003b2;-catenin turnover by down-regulating intracellular levels of &#x003b2;-catenin.</p></sec><sec><title>Results</title><p>To investigate whether Apc is involved in lineage commitment of skeletal precursor cells, we generated conditional knockout mice lacking functional <italic>Apc </italic>in <italic>Col2a1</italic>-expressing cells. In contrast to other models in which an oncogenic variant of &#x003b2;-catenin was used, our approach resulted in the accumulation of wild type &#x003b2;-catenin protein due to functional loss of Apc. Conditional homozygous <italic>Apc </italic>mutant mice died perinatally showing greatly impaired skeletogenesis. All endochondral bones were misshaped and lacked structural integrity. Lack of functional Apc resulted in a pleiotropic skeletal cell phenotype. The majority of the precursor cells lacking <italic>Apc </italic>failed to differentiate into chondrocytes or osteoblasts. However, skeletal precursor cells in the proximal ribs were able to escape the noxious effect of functional loss of Apc resulting in formation of highly active osteoblasts. Inactivation of Apc in chondrocytes was associated with dedifferentiation of these cells.</p></sec><sec><title>Conclusion</title><p>Our data indicate that a tight Apc-mediated control of &#x003b2;-catenin levels is essential for differentiation of skeletal precursors as well as for the maintenance of a chondrocytic phenotype in a spatio-temporal regulated manner.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>During vertebrate embryogenesis, the axial and appendicular skeleton develop through endochondral bone formation. In this process, mesenchymal cells aggregate to form a chondrocytic template that prefigures the shape of the future bone. At the periphery of this cartilaginous mold, osteoblasts differentiate to form the bone collar. The cartilaginous mold is eventually replaced by bone in a step-wise program. Besides chondrocytes and osteoblasts, the skeleton also contains osteoclasts, which are of haematopoietic origin and play pivotal roles in both cartilage and bone resorption and remodelling [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>].</p><p>Every step in the proliferation, differentiation, maturation, apoptosis, and resorption of both chondrocytes and osteoblasts is characterized by a specific transcriptional guideline [<xref ref-type="bibr" rid="B4">4</xref>]. Sox9, a high-mobility-group transcription factor, and Runx2, a Runt domain transcription factor, are both expressed in bi-potential skeletal precursor cells differentiating into either chondrocytes or osteoblasts [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. Sox9 and Runx2 play leading roles in lineage commitment of these precursors: upregulation of Sox9 leads to chondrogenic differentiation [<xref ref-type="bibr" rid="B8">8</xref>], while activation of Runx2 is required for their osteogenic commitment [<xref ref-type="bibr" rid="B9">9</xref>].</p><p>Recently, based on mouse models, the canonical Wnt/&#x003b2;-catenin signaling pathway was found to act upstream of Sox9 and Runx2. In this pathway, in the absence of a Wnt signal, cytosolic &#x003b2;-catenin is degraded by the ubiquitination/proteasome system upon its phosphorylation at specific Ser-Thr residues by a destruction complex consisting of scaffold proteins such as Axin1, Axin2 (also known as Conductin) and the adenomatous polyposis coli (APC) tumor suppressor, and two kinases, namely glycogen synthase kinase 3&#x003b2; (GSK3&#x003b2;) and casein-kinase 1&#x003b1; (CK1&#x003b1;). Binding of Wnt to a complex composed of the transmembrane frizzled receptor and low-density lipoprotein receptor-related protein 5 or 6 (LRP5 or 6) co-receptor results in inactivation of the destruction complex and accumulation of cytoplasmic &#x003b2;-catenin. Upon its nuclear translocation, &#x003b2;-catenin acts as transcriptional co-activator in complex with transcription factors of the TCF/LEF family, leading to transcriptional activation of Wnt target genes [<xref ref-type="bibr" rid="B10">10</xref>]. In wild type mouse embryos, high levels of &#x003b2;-catenin and activation of canonical Wnt signaling have been found in osteoblastic precursors in developing skull and limb bones [<xref ref-type="bibr" rid="B11">11</xref>]. Accumulating evidence suggests that increased levels of canonical Wnt/&#x003b2;-catenin signaling inhibit Sox9 expression and activity, and stimulate Runx2 expression, leading to decreased chondrocyte differentiation and increased osteoblast differentiation, respectively [<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B15">15</xref>]. Similar results have been found in transgenic mice with <italic>Wnt14 </italic>overexpression in <italic>Collagen 2a1 </italic>(<italic>Col2a1</italic>)-expressing cells [<xref ref-type="bibr" rid="B11">11</xref>].</p><p>It has been also demonstrated that &#x003b2;-catenin is required at an early stage to repress chondrocytic differentiation [<xref ref-type="bibr" rid="B15">15</xref>]. Upon conditional inactivation of <italic>&#x003b2;-catenin </italic>in the limb and head mesenchyme before or during early mesenchymal condensations, <italic>Prx1</italic>-expressing and <italic>Dermo1</italic>-expressing skeletal precursors, respectively, differentiate into chondrocytes instead of osteoblasts [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. Finally, results on both constitutively active and inactivated &#x003b2;-catenin in <italic>Osterix (Osx)</italic>-, <italic>Collagen 1a1 (Col1a1)</italic>- or <italic>Osteocalcin </italic>(<italic>Osc</italic>)-expressing osteoblasts suggest that Wnt/&#x003b2;-catenin signaling coordinates bone formation by controlling the differentiation and activity of both osteoblasts and osteoclasts in a sequential, stage-specific manner [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>].</p><p>Little is known about the mechanisms regulating &#x003b2;-catenin activity in skeletal precursors. Through its wide range of specific motifs and domains, APC is involved in multiple cellular processes such as signal transduction, cytoskeletal organization, apoptosis, cell adhesion and motility, cell fate determination, and chromosomal stability [<xref ref-type="bibr" rid="B18">18</xref>]. However, biochemical and genetic evidence has been provided showing that APC's main tumor suppressing activity resides in its ability to bind to &#x003b2;-catenin and induce its degradation, thereby acting as a strong negative regulator of the canonical Wnt pathway [<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B21">21</xref>].</p><p>Familial adenomatous polyposis (FAP) patients heterozygous for an <italic>APC </italic>mutation frequently develop osteomas and dental anomalies [<xref ref-type="bibr" rid="B22">22</xref>]. Heterozygous <italic>Apc</italic><sup>1638N </sup>mutant mice occasionally develop osteomas (R. Fodde, personal communication). Homozygosity for the severely truncated <italic>Apc</italic><sup>Min </sup>and for the more hypomorphic <italic>Apc</italic><sup>1638N </sup>allele in the mouse results in a failure of primitive ectoderm development shortly after implantation, leading to lethality prior to gastrulation [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. Mutant Apc disturbs the differentiation capacity of mouse embryonic stem (ES) cells in a quantitative and qualitative fashion depending on the dose of &#x003b2;-catenin signaling. Aberrant differentiation capacity of ES cells ranges from a strong differentiation blockade in case of two severely truncated <italic>Apc</italic><sup>Min </sup>alleles, to more specific neuroectodermal, dorsal mesodermal, and endodermal defects (e.g., no differentiation in bone or cartilage) in case of two hypomorphic <italic>Apc</italic><sup>1638N </sup>alleles [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. Osteoblast-specific loss of Apc in the mouse leads to early onset of dramatically increased bone deposition and to lethality early in life [<xref ref-type="bibr" rid="B17">17</xref>]. However, Apc has not yet been linked with a role in the differentiation of skeletal precursor cells.</p><p>Here, we report that skeletal precursors of the axial and appendicular skeleton, when exposed to an uncontrolled rise of the &#x003b2;-catenin level due to conditional inactivation of <italic>Apc</italic>, lose their differentiation capacity to both the chondrogenic and osteogenic lineage. Moreover, conditional <italic>Apc </italic>mutant ribs show enhanced osteoblast activity, while the mutant nasal septum displays chondrocyte dedifferentiation. These results provide the first genetic evidence that Apc plays a crucial role throughout mouse skeletogenesis by regulating the differentiation of skeletal progenitor cells and maintenance of chondrocytes.</p></sec><sec><title>Results</title><sec><title>Conditional Apc<sup>15lox </sup>mice and transgenic Col2a1-Cre mice</title><p>Recently, we (ECR-M and RF) generated a novel mouse model carrying a conditional <italic>Apc</italic><sup>15lox </sup>allele where exon 15, encoding the majority of the coding region of Apc, and the polyadenylation signal, is flanked by lox<italic>P </italic>sites. Mice heterozygous and homozygous for the conditional <italic>Apc</italic><sup>15lox </sup>allele did not show any major abnormalities or susceptibility to tumors. <italic>Apc<sup>&#x00394;15/+</sup></italic>mice, heterozygous for the <italic>Apc<sup>&#x00394;15</sup></italic>mutant allele obtained by germline Cre-mediated deletion of exon 15, developed multiple intestinal tumors at an early age similar to<italic> Apc<sup>Min/+</sup></italic>animals. These results indicate that Cre-mediated recombination of the <italic>Apc</italic><sup>15lox </sup>allele leads to inactivation of the Apc protein and to the constitutive activation of Wnt/&#x003b2;-catenin signaling (Robanus-Maandag et al., in preparation).</p><p>Next, we investigated the temporal and spatial expression pattern of <italic>Cre </italic>in transgenic Col2a1-<italic>Cre </italic>mice [<xref ref-type="bibr" rid="B27">27</xref>] using <italic>LacZ </italic>reporter mice ("Rosaflox") [<xref ref-type="bibr" rid="B28">28</xref>]. Col2a1-<italic>Cre</italic>;Rosaflox embryos expressed <italic>Cre </italic>specifically at all sites of endochondral bone formation (Fig. <xref ref-type="fig" rid="F1">1A</xref>). In accordance with previous studies suggesting that <italic>Col2a1 </italic>is already expressed at E9.5 in the sclerotome of the somites [<xref ref-type="bibr" rid="B29">29</xref>], we detected <italic>Cre </italic>activity (based on positive LacZ staining) in mesenchymal condensations forming the sclerotome at E9.5 (Fig. <xref ref-type="fig" rid="F1">1B</xref>). At E12.5, LacZ-positive cells were identified in cartilage primordia later forming the vertebrae, long bones, sternum and cranial bones (Fig. <xref ref-type="fig" rid="F1">1C</xref>; data not shown). As reported in other Col2a1-<italic>Cre </italic>mouse lines [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B30">30</xref>], we found LacZ staining in the perichondrium at E14.5 (data not shown), and in the periosteum and primary spongiosa of long bones at E16.5, sites where osteoblasts normally differentiate (Fig. <xref ref-type="fig" rid="F1">1D, D'</xref>). The early onset (E9.5) of the <italic>LacZ </italic>expression in the sclerotome as well as its presence at later developmental stages (E14.5 and E16.5) in cells of the osteogenic lineage prompted us to conclude that the Col2a1-<italic>Cre</italic>-mediated recombination occurred in skeletal precursors characterized by both a chondrogenic and osteogenic differentiation potential.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Col2a1-<italic>Cre</italic>;Rosaflox mice express <italic>Cre </italic>at sites of endochondral bone formation</bold>. (A-D) <italic>LacZ </italic>expression in Col2a1-<italic>Cre</italic>;Rosaflox embryos following <italic>Cre </italic>recombination, detected by whole-mount X-Gal staining. (A) Macroscopic picture of E12.5 Col2a1-Cre;Rosaflox embryo. (B) Transversal section of E9.5 embryo showing &#x003b2;-galactosidase-positive sclerotomal cells adjacent to the neural tube. (C) Transversal section of E12.5 embryo showing <italic>LacZ </italic>expression in vertebrae primordia. (D) Sagital section of E16.5 embryo showing LacZ expression in the femur. The boxed region in D is magnified in D' showing <italic>LacZ </italic>expression in the periosteum (arrow head), osteoblasts (red arrow) and osteocytes (black arrow). Ne, neuroepithelium; Sc, sclerotome; N, notochord; Fe, femur. Scale bars: 1 mm in A; 50 &#x003bc;m in B, D'; 100 &#x003bc;m in C, D.</p></caption><graphic xlink:href="1471-213X-9-26-1"/></fig></sec><sec><title>Heterozygous Apc<sup>15lox/+ </sup>mice do not show any skeletal defect upon Col2a1-driven Cre expression</title><p><italic>Apc</italic><sup>15lox/15lox </sup>mice were bred with Col2a1-<italic>Cre </italic>mice to generate conditional heterozygous Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/+ </sup>mice. Microscopical analysis performed on Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/+ </sup>and control <italic>Apc</italic><sup>15lox/+ </sup>embryos at various developmental stages (E12.5, E14.5, E16.5) displayed a normal spatio-temporal expression of all chondrogenic and osteogenic markers investigated (data not shown).</p><p>To study postnatal growth and bone acquisition, 18 Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/+ </sup>mice (7 males, 11 females) and 11 <italic>Apc</italic><sup>15lox/+ </sup>mice (7 males, 4 females) were monitored for 12 weeks after birth. Mice of both genotypes were healthy, similar in appearance, size, body length/weight ratio and growth rate (data not shown). We next assessed bone architecture in these animals by micro-computed tomography (&#x003bc;CT) of the distal femora. No difference was detected between Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/+ </sup>mice and gender-matched <italic>Apc</italic><sup>15lox/+ </sup>control littermates with respect to bone mineral density, trabecular bone volume fraction, trabecular number, trabecular thickness, and trabecular separation (Fig. <xref ref-type="fig" rid="F2">2A&#x02013;D</xref>; data not shown). We further wanted to study whether conditional heterozygous <italic>Apc </italic>inactivation would lead to skeletal anomalies later in life. For this purpose, 10 Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/+ </sup>mice (5 males and 5 females) and 5 <italic>Apc</italic><sup>15lox/+ </sup>male mice were followed for 24 months. At the end of this period, animals were sacrificed and tissues were analyzed microscopically using hematoxiline/eosine-stained sections. No important abnormalities could be distinguished in the skull, ribs, vertebral column and long bones. We evenly detected in both groups signs of cartilage degradation, fibrosis, and osteochondritis, pathological findings which most likely were all age-related (data not shown). Altogether, we considered conditional heterozygous <italic>Apc </italic>mutant embryos as controls for the next experiments.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Skeletal development occurs normally in Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/+ </sup>mice</bold>. (A-D) &#x003bc;CT analysis of the distal diaphysis of the femur did not reveal significant differences between 12-week-old Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/+ </sup>mice and control littermates in any of the parameters investigated: (A) trabecular bone volume [BV/TV (%)], (B) number of trabeculae [Tb.N (1/mm)], (C) trabecular thickness [Tb.Th (&#x003bc;m)], and (D) trabecular separation [Tb.Sp (mm)]. All data represent mean values &#x000b1; s.d</p></caption><graphic xlink:href="1471-213X-9-26-2"/></fig></sec><sec><title>Homozygous Col2a1-Cre;Apc<sup>15lox/15lox </sup>mice die perinatally due to severe defects in skeletogenesis</title><p>Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/+ </sup>mice were crossed with <italic>Apc</italic><sup>15lox/15lox </sup>mice to generate conditional homozygous Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>mice (1:4). None of these mice were found at one month of age among 77 liveborn offspring. Of 27 dead pups found within the first month after delivery, only 5 pups on the day after delivery were Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox</sup>. To further investigate the Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>phenotype, embryonic litters at various developmental stages were isolated. Eight of 31 embryos isolated between E16.5 and E19.5 were Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>(26%). We concluded that conditional homozygosity for this <italic>Apc </italic>mutant allele was perinatally lethal. At E12.5, Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryos, although normal in size, displayed poor mandible and limb outgrowth compared to control littermates (Fig. <xref ref-type="fig" rid="F3">3A</xref>). At E14.5 and E16.5, Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryos were much smaller in comparison to controls, displayed craniofacial abnormalities, short trunk, and an incomplete closure of both thoracic and abdominal cavities (Fig. <xref ref-type="fig" rid="F3">3B, C</xref>). Gross analysis further indicated a severe truncation of both upper and lower limbs. Already at E14.5, but more significantly at E16.5, Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryos presented large skin blisters especially in the dorso-lumbar region (Fig. <xref ref-type="fig" rid="F3">3C</xref>).</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Skeletogenesis is severely impaired in Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryos</bold>. (A-E) Greatly impaired skeletal development and growth arrest of Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryos. Gross appearance (A-C) and Alcian blue and Alizarin red staining (D-E) of skeletal preparations of Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryos and control littermates at indicated developmental stages. Conditional <italic>Apc </italic>mutants showed lack of mandible outgrowth (arrowheads), poor limb development (black arrows), and an open thoracic and abdominal cavity (red arrows). Scale bars: 1 mm.</p></caption><graphic xlink:href="1471-213X-9-26-3"/></fig><p>Skeletal preparations of mouse embryos stained with Alcian blue (chondrocyte matrix) and Alizarin red (mineralized matrix) of embryos at E14.5 revealed a clear difference in size between Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>mutants and control littermates (Fig. <xref ref-type="fig" rid="F3">3D</xref>). All mutant structures were severely misshaped and fragmented. Mutants failed to develop a cartilaginous mold of both the mandibles and the occipital bone. The axial skeleton contained patchy and irregular cartilaginous structures that did not organize in vertebrae. All 13 rib pairs could be individually distinguished, however, due to their inadequate orientation, size, and shape and due to lack of a sternum, no thoracic basket was formed (Fig. <xref ref-type="fig" rid="F4">4A, B</xref>). Distorted cartilage rudiments were found where forelimbs should normally arise (Fig. <xref ref-type="fig" rid="F4">4E, F</xref>), while no signs of bone formation were found in hindlimb rudiments. Furthermore, no cartilaginous primordia of pelvic bones were observed. Similar observations were made in Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryos at E16.5 (Fig. <xref ref-type="fig" rid="F3">3E</xref>). At this developmental stage however, distinct areas of mineralization were observed in most parts of the mutant skeleton. The mutant hind skull showed mineralized regions, whereas the control occipital and temporal bone primordias stained only with Alcian blue (Fig. <xref ref-type="fig" rid="F4">4I, J</xref>). Mutant proximal ribs in these Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryos were much thicker and shorter in comparison to those in control embryos, and stained intensively with Alizarin red (Fig. <xref ref-type="fig" rid="F4">4C, D</xref>). In the mutant forelimb, a hypoplastic scapula could be identified, whereas more distal components were agenetic and replaced by an irregular cartilaginous structure (Fig. <xref ref-type="fig" rid="F4">4G, H</xref>).</p><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Details of skeletal preparations</bold>. (A-D) Vertebral column of control and mutant littermates at E14.5 (A, B) and E16.5 (C, D). Mutant vertebrae lacked structural integrity (arrowheads). At E16.5, mineralization was enhanced in the proximal part of the mutant rib (arrow). (E-H) Forelimb of control and mutant littermates at E14.5 (E, F) and E16.5 (G, H). At E16.5, only the scapula was identified (arrowhead), while more distal parts were represented by patchy cartilage aggregations (arrow). (I, J) Skull of control and mutant littermates at E16.5. The mutant displayed mineral deposition in the back skull corresponding to the cartilaginous structure in the control (arrowheads). Scale bars: 3 mm in A-H; 1 mm in I, J.</p></caption><graphic xlink:href="1471-213X-9-26-4"/></fig></sec><sec><title>Loss of functional Apc inhibits differentiation of skeletal precursors</title><p>Lack of functional Apc results in accumulation of cytoplasmic &#x003b2;-catenin, which subsequently translocates into the nucleus. This process can be well detected by immunohistochemistry (IHC). To investigate endochondral bone formation in Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryos, we analyzed vertebra formation at E12.5 and E14.5, and humerus development at E16.5 using IHC for &#x003b2;-catenin in combination with Alcian blue staining, and <italic>in situ </italic>hybridization (ISH) for several chondrocyte- and osteoblast-specific genes. Strongly elevated levels of &#x003b2;-catenin were seen at all sites of endochondral ossification in the Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryos at E12.5, E14.5 and E16.5, indicating efficient Col2a1-<italic>Cre</italic>-mediated <italic>Apc </italic>inactivation.</p><p>At E12.5, transversal sections of control vertebral primordia showed normal mesenchymal cell condensation and subsequent chondrogenic differentiation (Fig. <xref ref-type="fig" rid="F5">5A&#x02013;C</xref>). Chondrocytes stained negatively for &#x003b2;-catenin, started to deposit an Alcian blue-stained matrix, and expressed the nascent chondrocyte markers <italic>Sox9 </italic>and <italic>Col2a1</italic>. In marked contrast, mutant sclerotomal cells failed to condense into skeletal primordias. They showed strong nuclear &#x003b2;-catenin staining and displayed a mesenchymal-like spindle shape morphology. These cells expressed neither <italic>Sox9</italic>, nor <italic>Col2a1</italic>, implying that conditional loss of functional Apc in skeletal precursors inhibited mesenchymal cell condensation and chondrogenic differentiation. Next, we investigated whether these cells had switched their commitment to the osteogenic lineage due to the accumulation of &#x003b2;-catenin. Surprisingly, they did not express the early osteoblast markers <italic>Runx2 </italic>and <italic>Col1a1</italic>, suggesting that &#x003b2;-catenin accumulation due to <italic>Apc </italic>inactivation impaired osteogenic differentiation of skeletal precursors as well (Fig. <xref ref-type="fig" rid="F5">5D, E</xref>).</p><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Abnormal axial skeleton formation of Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryos already detectable at E12.5</bold>. (A) Immunostaining for &#x003b2;-catenin combined with Alcian blue (AB) staining, and (B-E) gene expression analysis by in situ hybridization with indicated probes on consecutive transversal sections of the sclerotome of a Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryo and control littermate at E12.5. (F-J) Similar analysis of vertebrae primordia at E14.5. &#x003b2;-Catenin-positive spindle-shaped cells lacked expression of all indicated chondrogenic and osteogenic markers (arrowheads). Scale bars: 100 &#x003bc;m.</p></caption><graphic xlink:href="1471-213X-9-26-5"/></fig><p>At E14.5, chondrocytes in the control vertebrae did not stain positively for &#x003b2;-catenin, displayed an intensely Alcian blue-stained matrix and expressed both early (<italic>Sox9</italic>, <italic>Col2a1</italic>) and mature chondrocyte markers, like <italic>Indian hedgehog </italic>(<italic>Ihh</italic>) and <italic>Collagen 10a1 </italic>(<italic>Col10a1</italic>), indicating a normal progression of endochondral ossification (Fig. <xref ref-type="fig" rid="F5">5F&#x02013;J</xref>). Although somite formation was present, mutant vertebrae were heavily crumbled and failed to organize in a cartilaginous anlage. Occasionally Alcian blue-positive clusters of chondrocytes were seen, which lacked detectable &#x003b2;-catenin immunostaining and were positive for chondrogenic marker expression. These cells were probably derived from non-recombined cells due to mosaicism of <italic>Cre </italic>expression. Surrounding these cartilage islands, mesenchymal-like spindle-shaped cells were observed. Comparable to the defects observed at E12.5, these cells expressed high levels of nuclear &#x003b2;-catenin due to <italic>Apc </italic>inactivation and lacked not only an Alcian blue-positive matrix but also expression of both chondrogenic and osteogenic markers (Fig. <xref ref-type="fig" rid="F5">5F&#x02013;J</xref>; data not shown).</p><p>At E16.5, chondrocytes of control proximal humeri did not express detectable &#x003b2;-catenin protein levels and were surrounded by a proteoglycan-rich matrix, which stained positively with both Alcian blue and Toluidine blue (Fig. <xref ref-type="fig" rid="F6">6A, B</xref>). They were organized in growth plates with a characteristic spatial expression pattern of the chondrogenic markers <italic>Sox9</italic>, <italic>Col2a1</italic>, <italic>Ihh</italic>, and <italic>Col10a1 </italic>(Fig. <xref ref-type="fig" rid="F6">6C&#x02013;F</xref>). Young osteoblasts in the perichondrium, periosteum and primary spongiosa were surrounded by a mineralized osteoid as detected by von Kossa staining (Fig. <xref ref-type="fig" rid="F6">6B</xref>) and expressed <italic>Runx2 </italic>and <italic>Col1a1 </italic>(Fig. <xref ref-type="fig" rid="F6">6G, H</xref>). Mature osteoblasts expressed <italic>Osc </italic>(Fig. <xref ref-type="fig" rid="F6">6I</xref>), while osteoclasts expressed Matrix metalloproteinase 9 (<italic>Mmp9</italic>) (Fig. <xref ref-type="fig" rid="F6">6J</xref>). In contrast, mutant humeri were completely misshaped and contained nuclear &#x003b2;-catenin-positive cells that were organized in clusters, showing a mesenchymal-like shape (Fig. <xref ref-type="fig" rid="F6">6A</xref>). Similar to our observations at E12.5 and E14.5, these cells expressed neither chondrogenic, nor osteogenic markers (Fig. <xref ref-type="fig" rid="F6">6C&#x02013;I</xref>). In addition, no <italic>Mmp9 </italic>expression could be detected (Fig. <xref ref-type="fig" rid="F6">6J</xref>), suggesting that differentiation of bone-resorbing cells was impaired as well. These &#x003b2;-catenin-positive cell clusters were surrounded by chondrocytes expressing <italic>Sox9 </italic>and <italic>Col2a </italic>and lacked positive staining for &#x003b2;-catenin. These cell most likely have not undergone a recombination event as observed at E14.5 (Fig. <xref ref-type="fig" rid="F6">6A, C, D</xref>).</p><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>No chondrogenic and osteogenic differentiation in the developing humerus due to lack of functional <italic>Apc</italic></bold>. (A-B) Immunostaining for &#x003b2;-catenin combined with Alcian blue (AB) staining (A), combined von Kossa-Toluidine blue staining (B), and (C-J) gene expression analysis by in situ hybridization with indicated probes for (C-F) chondrocytes, (G-I) osteoblasts and (J) osteoclasts on consecutive transversal sections of the developing humerus of a Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryo and control littermate at E16.5. &#x003b2;-Catenin-positive spindle-shaped cells organized in clusters and failed to express chondrogenic and osteogenic markers (arrowheads). &#x003b2;-Catenin-negative cells at the periphery of these clusters expressed early chondrogenic markers only (arrows), probably due to lack of Cre-mediated loss of functional <italic>Apc</italic>. Scale bars: 100 &#x003bc;m.</p></caption><graphic xlink:href="1471-213X-9-26-6"/></fig></sec><sec><title>Increased osteoblastogenesis in proximal ribs of Col2a1-Cre;Apc<sup>15lox/15lox </sup>embryos</title><p>Despite the inhibitory effect of <italic>Apc </italic>inactivation on differentiation of skeletal precursors in long bones and vertebrae, proximal ribs of Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryos at E16.5 showed clearly enhanced mineralization upon skeletal staining (Fig. <xref ref-type="fig" rid="F4">4D</xref>). Therefore, we analyzed the development of these skeletal structures in more detail. The ribs develop through endochondral ossification from the paired lateral sclerotomic areas [<xref ref-type="bibr" rid="B31">31</xref>]. Formation of the proximal rib depends on the notochord and the ventral neural tube, whereas development of the distal part depends on the surface ectoderm [<xref ref-type="bibr" rid="B32">32</xref>]. At E14.5, proximal ribs of control embryos were cartilaginous and contained mature chondrocytes that did not stain for &#x003b2;-catenin (Fig. <xref ref-type="fig" rid="F7">7A&#x02013;C</xref>). Mutant proximal ribs were severely misshaped and contained &#x003b2;-catenin negatively stained cartilage islands, accounting for the positive Alcian blue staining observed upon skeletal preparation (Fig. <xref ref-type="fig" rid="F4">4B</xref>, <xref ref-type="fig" rid="F7">7A</xref>). &#x003b2;-Catenin-positive cells were negative for chondrogenic and osteogenic markers (Fig. <xref ref-type="fig" rid="F7">7A&#x02013;D</xref>). At E16.5, the &#x003b2;-catenin-negative proximal ribs of control embryos consisted of cartilage and mineralized bone matrix as indicated by combined von Kossa-Toluidine blue staining (Fig. <xref ref-type="fig" rid="F7">7E, F</xref>; data not shown). They contained chondrocytes, osteoblasts, and osteoclasts as assessed by ISH (Fig. <xref ref-type="fig" rid="F7">7H&#x02013;K</xref>; data not shown). In contrast, proximal ribs of mutant littermates stained strongly positive for &#x003b2;-catenin and were significantly thicker and shorter compared to those of control embryos (Fig. <xref ref-type="fig" rid="F4">4C, D</xref> and <xref ref-type="fig" rid="F7">7E&#x02013;G</xref>). They consisted of a massive mineralized bone matrix and a poorly developed bone marrow cavity, although osteoclast differentiation and activity were normal as assessed by ISH for <italic>Mmp9 </italic>and TRAP staining, respectively (Fig. <xref ref-type="fig" rid="F7">7K, L, L'</xref>). Interestingly, &#x003b2;-catenin-positive cells expressed all osteogenic markers analyzed (<italic>Runx2</italic>, <italic>Col1a1</italic>, and <italic>Osc</italic>), indicating that, unlike in the long bones and vertebrae, <italic>Apc </italic>inactivation in skeletal precursors of the proximal ribs did not impair osteoblastogenesis (Fig. <xref ref-type="fig" rid="F7">7H&#x02013;J</xref>). Since Ihh is a critical regulator of osteoblastogenesis, we subsequently tested whether the increased ossification might be due to increased <italic>Ihh </italic>expression in the non-recombined neighbouring chondrocytes. The &#x003b2;-catenin-negative cells, however, matured normally expressing all chondrocyte markers investigated (<italic>Sox9, Col2a1, Ihh and Col10a1</italic>) at similar levels compared to control cartilage (data not shown). The abundant presence of a bone matrix combined with evidence of functional osteoclasts suggested that the &#x003b2;-catenin-positive osteoblasts were sclerotic.</p><fig position="float" id="F7"><label>Figure 7</label><caption><p><bold>Conditional <italic>Apc </italic>inactivation enhances osteoblast formation and mineral deposition in the developing proximal rib</bold>. (A-L) Immunostaining for &#x003b2;-catenin combined with Alcian blue (AB) staining (A, E), combined von Kossa-Toluidine blue staining (F), hematoxylin/eosin staining (G), gene expression analysis by in situ hybridization with indicated probes for chondrogenic (B, C), osteogenic (D, H-J) and osteoclastogenic differentiation (K) on consecutive transversal sections of the developing proximal rib of a Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryo and control littermate at E14.5 (A-D) and E16.5 (E-K). The double-headed arrows in G indicate the thickness of the rib. (L) Tartrate-resistant acid phosphatase (TRAP) staining of the developing proximal rib of a Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryo at E16.5. The boxed region in L is magnified in L' showing multinucleated osteoclasts (arrowheads) staining positive for TRAP. Scale bars: 100 &#x003bc;m in A-L; 50 &#x003bc;m in L'.</p></caption><graphic xlink:href="1471-213X-9-26-7"/></fig></sec><sec><title>Chondrocyte dedifferentiation in the nasal septum of Col2a1-Cre;Apc<sup>15lox/15lox </sup>embryos</title><p>The nasal septum is a midline vertical plate of hyaline cartilage, which undergoes endochondral ossification in postnatal life [<xref ref-type="bibr" rid="B33">33</xref>]. Endochondral ossification of the caudal and dorsal borders of the septum, when combined with interstitial expansion, has the effect of displacing the facial skeleton away from the neurocranium and thus enlarging the skull [<xref ref-type="bibr" rid="B34">34</xref>]. At E16.5, chondrocytes forming the nasal septum of control mice did not stain for &#x003b2;-catenin, were surrounded by an Alcian blue-positive matrix, and expressed <italic>Sox9 </italic>and <italic>Col2a1 </italic>(Fig. <xref ref-type="fig" rid="F8">8A&#x02013;D</xref>). In the mutant nasal cartilage we distinguished crumbled chondrogenic islands surrounded by &#x003b2;-catenin-positive cells with an undifferentiated mesenchymal-like phenotype (Fig. <xref ref-type="fig" rid="F8">8F&#x02013;H</xref>). The chondrogenic islands consisted of round cells embedded in chondrons surrounded by extracellular matrix (ECM) (Fig. <xref ref-type="fig" rid="F8">8E</xref>). Interestingly, molecular analysis of these chondrogenic islands revealed the presence of two cell populations: &#x003b2;-catenin-negative and &#x003b2;-catenin-positive cells. The former expressed chondrogenic markers like <italic>Sox9 </italic>and <italic>Col2a1</italic>, and their ECM stained positive with Alcian blue, whereas the latter did not express any chondrogenic or osteogenic markers, while their ECM stained significantly less with Alcian blue (Fig. <xref ref-type="fig" rid="F8">8F&#x02013;I</xref>; data not shown).</p><fig position="float" id="F8"><label>Figure 8</label><caption><p><bold>Dedifferentiation in the nasal septum of Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryos at E16.5</bold>. (A, E) Hematoxylin/eosin staining, (B, F, H) immunostaining for &#x003b2;-catenin combined with Alcian blue (AB) staining, and (C-D, G, I) gene expression analysis by in situ hybridization with indicated probes for chondrogenic differentiation on consecutive transversal sections of the developing nasal septum of a Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryo and control littermate at E16.5. (F', G', H', I') High magnification pictures of the boxed regions in F, G, H, and I, respectively. Mesenchymal-like &#x003b2;-catenin-positive cells (arrow in F, H) were present between crumbled cartilage islands. Within these cartilage islands, although displaying chondrocytic morphology and an Alcian blue stained matrix, most of the &#x003b2;-catenin-positive cells did not express <italic>Sox9 </italic>(arrowheads in G') or <italic>Col2a1 </italic>(arrows in I'). Scale bars: 100 &#x003bc;m in A, E, F, H; 5 &#x003bc;m in F', H'.</p></caption><graphic xlink:href="1471-213X-9-26-8"/></fig><p>The presence of &#x003b2;-catenin-positive cells in the chondrogenic islands suggested that these cells, due to mosaicism of <italic>Cre </italic>expression, had initiated normal chondrocyte differentiation before undergoing <italic>Apc </italic>inactivation. Subsequently, the increased level of &#x003b2;-catenin triggered the loss of expression of the early chondrogenic markers and initiated degradation of the ECM. These observations were indicative of dedifferentiated chondrocytes. Similar observations were made in cartilaginous rudiments at other sites of endochondral bone formation, but the effect was most pronounced in the nasal septum (data not shown).</p></sec></sec><sec><title>Discussion</title><sec><title>Conditional homozygous loss of functional Apc severely disrupts mouse skeletogenesis via stabilized &#x003b2;-catenin</title><p>According to most of the transgenic mouse studies reported, levels of &#x003b2;-catenin, the effector of the canonical Wnt ligands, need to be downregulated in skeletal precursor cells to enable chondrogenic differentiation, whereas elevated &#x003b2;-catenin levels promote differentiation into osteoblasts [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>]. This theory is partly based on observations in heterozygous gain-of-function models in which Cre-mediated recombination results in the expression of oncogenic &#x003b2;-catenin. The cellular mechanisms controlling the biological effects of oncogenic &#x003b2;-catenin in the presence of wild type &#x003b2;-catenin are largely unknown. In addition, there are no reports on the role of Apc in regulation of skeletal precursor differentiation via control of &#x003b2;-catenin in the mouse. Here, we have focused on this important role of the multifunctional protein Apc, binding to and downregulating &#x003b2;-catenin. We have selectively inactivated one or both alleles of <italic>Apc </italic>in murine <italic>Col2a1</italic>-expressing cells. Our data indicate that the <italic>Col2a1 </italic>promoter is suitable for this study, since Cre-mediated recombination starts very early (E9.5) in skeletal precursor cells that have not yet committed to the chondrogenic or the osteogenic lineage, consistent with previous findings in other Col2a1-<italic>Cre </italic>lines [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B30">30</xref>].</p><p>Conditional heterozygous inactivation of <italic>Apc </italic>does not result in a detectable level of its target &#x003b2;-catenin as determined by IHC. Moreover, heterozygous Col2a1-<italic>Cre</italic>-mediated <italic>Apc </italic>inactivation does not interfere with embryonic skeletal development, postnatal growth or bone acquisition up to 24 months of age, as determined by histological and &#x003bc;CT analysis. Our data imply that the level of Apc protein produced by a single functional <italic>Apc </italic>allele is sufficient to mediate appropriate &#x003b2;-catenin degradation. This is in agreement with normal body weight, size, and growth of young Apc<sup>Min/+ </sup>mice [<xref ref-type="bibr" rid="B37">37</xref>].</p><p>In marked contrast, conditional inactivation of <italic>Apc </italic>results in a strongly elevated level of (wild type) &#x003b2;-catenin in skeletal precursors, leading to greatly impaired embryogenesis and perinatal lethality. The significantly reduced size and the vast range of skeletal malformations in these embryos is most likely due to the specific Col2a1-<italic>Cre </italic>activity in skeletal primordias at a very early embryonic stage starting at E9.5 resulting in massive &#x003b2;-catenin accumulation in the developing endochondral skeleton. Probably several factors, like the open rib cage and the severe malformation, from E14.5 on have led to the perinatal lethality. The loss of the multiple &#x003b2;-catenin-independent functions of the Apc protein might have contributed to the gravity and complexity of the skeletal phenotype observed in Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>mice as well [<xref ref-type="bibr" rid="B18">18</xref>]. Moreover, since <italic>Col2a1 </italic>expression is not completely restricted to skeletal tissues during mouse embryogenesis [<xref ref-type="bibr" rid="B29">29</xref>], we can not exclude that the severity of the phenotype might have been partly due to loss of functional <italic>Apc </italic>in other Col2a1-<italic>Cre</italic>-expressing cell types.</p></sec><sec><title>Apc is crucial for both chondrogenic and osteogenic differentiation of skeletal precursors</title><p>Wnt/&#x003b2;-catenin signaling represents a mechanism in mesenchymal precursor cells for selecting between chondrocytic and osteoblastic fates. This key regulating role in lineage commitment has been attributed to &#x003b2;-catenin. Indeed, conditional gain-of-function mutation of <italic>&#x003b2;-catenin </italic>leads to decreased chondrocyte differentiation in <italic>Prx1</italic>-expressing and <italic>Col2a1</italic>-expressing cells [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. However, corresponding increased osteoblast differentiation has not been observed in these models, instead, a decreased osteoblast marker expression has been seen in case of <italic>Prx1</italic>-expressing cells, suggesting that activation of &#x003b2;-catenin negatively affects skeletogenesis [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. In addition, conditional loss-of-function mutation of <italic>&#x003b2;-catenin </italic>in <italic>Prx1</italic>-expressing cells leads to increased expression of not only chondrocyte but also early osteoblast markers [<xref ref-type="bibr" rid="B15">15</xref>]. These data strongly suggest that &#x003b2;-catenin negatively regulates the differentiation of mesenchymal cells into a common skeletal precursor [<xref ref-type="bibr" rid="B38">38</xref>].</p><p>We report here that in the vast majority of endochondral skeletal elements, precursor cells lacking functional Apc express strong nuclear &#x003b2;-catenin staining and fail to differentiate into both chondrogenic and osteogenic lineages. These data are in line with the inability of mouse embryonic stem cells carrying specific bi-allelic <italic>Apc </italic>mutations to differentiate into bone and cartilage [<xref ref-type="bibr" rid="B25">25</xref>]. Our data are also consistent with those based on conditional stabilization of &#x003b2;-catenin in mesenchymal skeletal precursors which had an undifferentiated appearance [<xref ref-type="bibr" rid="B15">15</xref>]. This consistency strongly suggests that, notwithstanding the multiple functions of Apc, its &#x003b2;-catenin-controlling role is the most important during skeletogenesis. We conclude that Apc plays a crucial role in differentiation of skeletal precursors in vertebrae and long bones: it enables the differentiation into both skeletal lineages by decreasing the level of &#x003b2;-catenin.</p></sec><sec><title>Loss of functional Apc in skeletal precursors of the proximal rib stimulates osteogenesis</title><p>Although in the vast majority of the endochondral skeleton both chondrogenic and osteogenic differentiation is inhibited due to loss of functional <italic>Apc </italic>in skeletal precursors, we find a different phenotype in the proximal ribs. Notwithstanding the cartilaginous structure at E14.5, proximal ribs of Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>mutants at E16.5 show abundant bone matrix deposited by osteoblasts, invariably expressing high levels of nuclear &#x003b2;-catenin. Since osteoblasts do not express <italic>Col2a1</italic>, these cells are most likely derived from <italic>Col2a1</italic>-expressing skeletal precursors lacking functional Apc. This implies that, in contrast to other skeletal elements, skeletal precursors of the proximal ribs are able to escape from the noxious effects of strongly elevated &#x003b2;-catenin levels on differentiation of precursor cells by an as yet unknown mechanism. Since <italic>Ihh </italic>expression is normal in the non-recombined neighbouring chondrocytes, we speculate that Ihh may be a prime target for inducing osteoblastogenesis in the recombined precursor cells counteracting the noxious effect of &#x003b2;-catenin.</p><p>Despite the evidence of functional osteoclasts, the intensely ossified proximal ribs show a strongly diminished bone marrow cavity, rendering it likely that the increased bone formation is due to osteosclerosis. These observations are in agreement with other data, showing that enhanced canonical Wnt signaling can increase bone mass through stimulation of osteoblast activity rather than inhibition of osteoclast formation and activity [<xref ref-type="bibr" rid="B39">39</xref>-<xref ref-type="bibr" rid="B41">41</xref>]. Such an osteopetrotic phenotype has only been seen in mice with conditional loss of functional <italic>Apc </italic>or constitutively active &#x003b2;-catenin in already differentiated osteoblasts, resulting in dramatically increased bone deposition [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B42">42</xref>].</p></sec><sec><title>Functional Apc is required to maintain the chondrocyte phenotype</title><p>We have found clear evidence for the occurrence of chondrocyte dedifferentiation due to &#x003b2;-catenin accumulation in the nasal septum. Morphologically characterized chondrocytes, which were nuclear &#x003b2;-catenin-positive, lacked expression of typical chondrocyte markers. Furthermore, they were imbedded in an ECM containing significantly less proteoglycans.</p><p>Given the noxious effect of increased &#x003b2;-catenin levels on chondrocyte formation (our data and [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>]), these cells most likely have undergone Cre-mediated loss of functional <italic>Apc </italic>after completion of the initial stages of chondrocyte differentiation. Mouse models with an increased level of &#x003b2;-catenin in <italic>Col2a1</italic>-expressing cells show accelerated chondrocyte maturation [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. We have found no indication for this phenomenon, implying that the high level of &#x003b2;-catenin due to loss of <italic>Apc </italic>does not result in chondrocyte maturation but in chondrocyte dedifferentiation. Our data suggest that accumulated &#x003b2;-catenin triggers this dedifferentiation program not only through inhibition of chondrogenic marker expression but also by enhancing the loss of ECM presumably through stimulation of matrix-degrading enzymes. It has been demonstrated that &#x003b2;-catenin increases expression and activity of a number of enzymes involved in matrix degradation [<xref ref-type="bibr" rid="B43">43</xref>-<xref ref-type="bibr" rid="B45">45</xref>]. &#x003b2;-Catenin stabilization has been associated with dedifferentiation of articular chondrocytes in vitro upon serial monolayer culture, or treatment with retinoic acid or IL1&#x003b2; [<xref ref-type="bibr" rid="B46">46</xref>]. Dedifferentiated chondrocytes have also been observed at other sites of endochondral bone formation in the Col2a1-<italic>Cre</italic>;<italic>Apc</italic><sup>15lox/15lox </sup>embryos, however, the presence of these cells was most pronounced in the nasal septum. Altogether, our data indicate that Apc is required to suppress &#x003b2;-catenin for maintenance of the chondrocytic phenotype.</p></sec></sec><sec><title>Conclusion</title><p>We show here for the first time that Apc, by negatively controlling the levels of &#x003b2;-catenin, is a critical regulator of the differentiation of skeletal progenitor cells. Conditional inactivation of the mouse <italic>Apc </italic>gene results in a heterogeneous skeletal phenotype. Based on our results, we postulate that Apc-mediated control of the dosage of transcriptionally active &#x003b2;-catenin protein is directive for the differentiation program of skeletal precursor cells. In the vast majority of the skeletal precursors, loss of functional <italic>Apc </italic>leads to a strongly increased &#x003b2;-catenin level, resulting in the formation of an undifferentiated mesenchymal cell, which lacks differentiation potential for both osteogenic and chondrogenic lineages. When the inhibitory effect of a strongly increased &#x003b2;-catenin level in the skeletal precursors is reduced, highly active osteoblasts arise. Strong repression of &#x003b2;-catenin in these precursors is required for chondrogenesis. Support for our hypothesis on the importance of the dosage of Apc and &#x003b2;-catenin is provided by observations in Col2a1-<italic>Wnt14 </italic>transgenic mice [<xref ref-type="bibr" rid="B11">11</xref>]. Higher levels of <italic>Wnt14 </italic>expression resulting in a high level of &#x003b2;-catenin block differentiation of skeletal precursors into chondrocytes or osteoblasts, whereas lower levels of <italic>Wnt14 </italic>expression result in enhanced ossification. We provide evidence that Apc plays a crucial role in modulating the &#x003b2;-catenin level during mouse skeletogenesis in a spatio-temporal regulated manner. In skeletal precursor cells, Apc is required for differentiation into both chondrocytes and osteoblasts. In addition, Apc is essential in chondrocytes to maintain their phenotype and enable their maturation.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Transgenic mice</title><p>All animal studies were approved by the ethical committee of the Leiden University Medical Centre and complied with national laws relating to the conduct of animal experiments. The <italic>Apc</italic><sup>15lox/+ </sup>mouse was generated by gene targeting in IB10 embryonic stem cells, using a 22.5 kb targeting vector containing lox<italic>P </italic>sites flanking the last exon of <italic>Apc</italic>, i.e. exon 15. Lox<italic>P </italic>sites were inserted in the <italic>Bgl</italic>II site of intron 14 and in the <italic>Apa</italic>I site approximately 350 bp downstream of the <italic>Apc </italic>polyadenylation signal. Exon 15 of the <italic>Apc </italic>gene encodes for codons 660 to 2842 of the Apc protein and harbours all the functional domains of Apc involved in &#x003b2;-catenin regulation as well as the C-terminal domains binding to microtubules, DLG, and EB1. Therefore, following Cre-mediated deletion of exon 15, functionality of the remaining protein will be fully impaired with respect to the main function of Apc, i.e. &#x003b2;-catenin regulating. Moreover, as deletion of exon 15 also removes the polyadenylation signal, no stable mRNA is produced and as a consequence no stable truncated protein will be generated. A full description of this new conditional <italic>Apc </italic>mouse model is currently in preparation (Robanus-Maandag et al., in preparation). Col2a1-<italic>Cre </italic>mice [<xref ref-type="bibr" rid="B27">27</xref>] were mated with <italic>Apc</italic><sup>15lox/15lox </sup>mice. Of the offspring, Col2a1-<italic>Cre</italic><sup>+/-</sup>;<italic>Apc</italic><sup>15lox/+ </sup>mice were mated with <italic>Apc</italic><sup>15lox/15lox </sup>mice to obtain Col2a1-<italic>Cre</italic><sup>+/-</sup>;<italic>Apc</italic><sup>15lox/15lox </sup>mice. <italic>LacZ </italic>reporter mice were obtained from Dr. Xiaohong Mao [<xref ref-type="bibr" rid="B28">28</xref>]. Routine mouse genotyping was performed on tail DNAs by PCR (Robanus-Maandag et al., in preparation).</p></sec><sec><title>Skeletal analysis</title><p>Skeletons of mouse embryos were stained with Alcian blue and Alizarin red for cartilaginous and mineralized tissues, respectively, according to standard procedures [<xref ref-type="bibr" rid="B47">47</xref>]. For micro-computed tomography (&#x003bc;CT) analysis, femora were recovered from 12-week-old mice after death and processed as described [<xref ref-type="bibr" rid="B48">48</xref>].</p></sec><sec><title>&#x003b2;-galactosidase staining, Histology, Immunohistochemistry, In Situ Hybridization</title><p>Whole mount &#x003b2;-galactosidase staining was performed as described [<xref ref-type="bibr" rid="B49">49</xref>], from E16.5 on after removal of the skin. For histology, immunohistochemistry, and in situ hybridization, specimens were fixed in phosphate-buffered formalin, embedded in paraffin, and sectioned at 6 &#x003bc;m. Hematoxylin/eosin, Nuclear red, Toluidine blue, and von Kossa stainings were performed according to standard procedures. For immunohistochemistry, sections were treated with 1% H<sub>2</sub>O<sub>2 </sub>in 40% methanol/60% TBS for 30 minutes to reduce endogenous peroxidase activity. For antigen retrieval the sections were boiled in Tris-EDTA pH 9.0 for 20 minutes. Blocking was performed with 5% blocking buffer for 30 minutes at 37&#x000b0;C (Boehringer Ingelheim). Sections were incubated with the primary mouse monoclonal antibody against &#x003b2;-catenin (1:100; BD Transduction Laboratories) overnight at 4&#x000b0;C, followed by incubation with the second antibody biotin-conjugated rabbit anti-mouse IgG (1:300; Amersham Biosciences) for 45 minutes at 37&#x000b0;C. The biotinylated proteins were detected by incubation with horseradish peroxidase-conjugated streptavidin (1:200; Amersham Biosciences) for 30 minutes at 37&#x000b0;C and visualized with DAB (Sigma). After counterstaining with Alcian blue for 15 minutes and hematoxylin for 1 minute, sections were dehydrated and embedded in Histomount (BDH). For in situ hybridization, digoxigenin-labeled single-stranded RNA probes were prepared using a DIG RNA labeling kit (Boehringer) following the manufacturers' instructions. All probes are available upon request. In situ hybridization was carried out as described [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B50">50</xref>]. Images were taken with a DXM-1200 digital camera (Nikon).</p></sec></sec><sec><title>Authors' contributions</title><p>The studies were designed and initiated by MK as principal investigator, with the help of RF and ECR-M; Col2a1-<italic>Cre </italic>mice were provided by TK and HMK; mutant mice were generated and genotyped by CAJB and ECR-M; embryo experimental work and analysis were performed by RLM; &#x003bc;CT analysis was performed by GR; data interpretation was carried out by RLM assisted by MK, GH, MAV, PA, CWGML, RF, JMW, and ECR-M; the manuscript was written by RLM with the assistance of all co-authors. All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank Christine Hartmann (IMP, Vienna, Austria) for the mouse <italic>Runx2</italic>, <italic>Sox9</italic>, <italic>Osc</italic>, and <italic>Ihh </italic>probes, Eero Vuorio (University of Turku, Finland) for the mouse <italic>Col1a1 </italic>and <italic>Col2a1 </italic>probes, and Willy Hofstetter (University of Bern, Switzerland) for the mouse <italic>Col10a1 </italic>probe.</p><p>This work was financially supported by a short-term research fellowship from the European Society for Pediatric Endocrinology (RLM), an unrestricted educational grant from IPSEN FARMACEUTICA BV (RLM), a research grant from The Human Growth Foundation (MK), and a research grant from the Association for International Cancer Research (CAJB).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karsenty</surname><given-names>G</given-names></name></person-group><article-title>Genetics of skeletogenesis</article-title><source>Dev Genet</source><year>1998</year><volume>22</volume><fpage>301</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">9664683</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1520-6408(1998)22:4&#x0003c;301::AID-DVG1&#x0003e;3.0.CO;2-A</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karsenty</surname><given-names>G</given-names></name><name><surname>Wagner</surname><given-names>EF</given-names></name></person-group><article-title>Reaching a genetic and molecular understanding of skeletal development</article-title><source>Dev Cell</source><year>2002</year><volume>2</volume><fpage>389</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">11970890</pub-id><pub-id pub-id-type="doi">10.1016/S1534-5807(02)00157-0</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tuan</surname><given-names>RS</given-names></name></person-group><article-title>Biology of developmental and regenerative skeletogenesis</article-title><source>Clin Orthop Relat Res</source><year>2004</year><fpage>S105</fpage><lpage>S117</lpage><pub-id pub-id-type="pmid">15480052</pub-id><pub-id pub-id-type="doi">10.1097/01.blo.0000143560.41767.ee</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>BR</given-names></name><name><surname>Reginato</surname><given-names>AM</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group><article-title>Bone development</article-title><source>Annu Rev Cell Dev Biol</source><year>2000</year><volume>16</volume><fpage>191</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">11031235</pub-id><pub-id pub-id-type="doi">10.1146/annurev.cellbio.16.1.191</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akiyama</surname><given-names>H</given-names></name><name><surname>Chaboissier</surname><given-names>MC</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name><name><surname>Schedl</surname><given-names>A</given-names></name><name><surname>de Crombrugghe</surname><given-names>B</given-names></name></person-group><article-title>The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6</article-title><source>Genes Dev</source><year>2002</year><volume>16</volume><fpage>2813</fpage><lpage>2828</lpage><pub-id pub-id-type="pmid">12414734</pub-id><pub-id pub-id-type="doi">10.1101/gad.1017802</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>N</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Lian</surname><given-names>JB</given-names></name><name><surname>Pratap</surname><given-names>J</given-names></name><name><surname>Kingsley</surname><given-names>PD</given-names></name><name><surname>van Wijnen</surname><given-names>AJ</given-names></name><name><surname>Stein</surname><given-names>JL</given-names></name><name><surname>Schwarz</surname><given-names>EM</given-names></name><name><surname>O'Keefe</surname><given-names>RJ</given-names></name><name><surname>Stein</surname><given-names>GS</given-names></name><etal></etal></person-group><article-title>Overlapping expression of Runx1(Cbfa2) and Runx2(Cbfa1) transcription factors supports cooperative induction of skeletal development</article-title><source>J Cell Physiol</source><year>2005</year><volume>203</volume><fpage>133</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">15389629</pub-id><pub-id pub-id-type="doi">10.1002/jcp.20210</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Engin</surname><given-names>F</given-names></name><name><surname>Munivez</surname><given-names>E</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Sebald</surname><given-names>E</given-names></name><name><surname>Krakow</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name></person-group><article-title>Dominance of SOX9 function over RUNX2 during skeletogenesis</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>19004</fpage><lpage>19009</lpage><pub-id pub-id-type="pmid">17142326</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0605170103</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lefebvre</surname><given-names>V</given-names></name><name><surname>Smits</surname><given-names>P</given-names></name></person-group><article-title>Transcriptional control of chondrocyte fate and differentiation</article-title><source>Birth Defects Res C Embryo Today</source><year>2005</year><volume>75</volume><fpage>200</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">16187326</pub-id><pub-id pub-id-type="doi">10.1002/bdrc.20048</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Kronenberg</surname><given-names>H</given-names></name></person-group><article-title>Minireview: transcriptional regulation in development of bone</article-title><source>Endocrinology</source><year>2005</year><volume>146</volume><fpage>1012</fpage><lpage>1017</lpage><pub-id pub-id-type="pmid">15604211</pub-id><pub-id pub-id-type="doi">10.1210/en.2004-1343</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><article-title>Wnt/beta-catenin signaling in development and disease</article-title><source>Cell</source><year>2006</year><volume>127</volume><fpage>469</fpage><lpage>480</lpage><pub-id pub-id-type="pmid">17081971</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2006.10.018</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>TF</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Garrett-Beal</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group><article-title>Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis</article-title><source>Dev Cell</source><year>2005</year><volume>8</volume><fpage>739</fpage><lpage>750</lpage><pub-id pub-id-type="pmid">15866164</pub-id><pub-id pub-id-type="doi">10.1016/j.devcel.2005.03.016</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akiyama</surname><given-names>H</given-names></name><name><surname>Lyons</surname><given-names>JP</given-names></name><name><surname>Mori-Akiyama</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Deng</surname><given-names>JM</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Behringer</surname><given-names>RR</given-names></name><etal></etal></person-group><article-title>Interactions between Sox9 and beta-catenin control chondrocyte differentiation</article-title><source>Genes Dev</source><year>2004</year><volume>18</volume><fpage>1072</fpage><lpage>1087</lpage><pub-id pub-id-type="pmid">15132997</pub-id><pub-id pub-id-type="doi">10.1101/gad.1171104</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gaur</surname><given-names>T</given-names></name><name><surname>Lengner</surname><given-names>CJ</given-names></name><name><surname>Hovhannisyan</surname><given-names>H</given-names></name><name><surname>Bhat</surname><given-names>RA</given-names></name><name><surname>Bodine</surname><given-names>PV</given-names></name><name><surname>Komm</surname><given-names>BS</given-names></name><name><surname>Javed</surname><given-names>A</given-names></name><name><surname>van Wijnen</surname><given-names>AJ</given-names></name><name><surname>Stein</surname><given-names>JL</given-names></name><name><surname>Stein</surname><given-names>GS</given-names></name><etal></etal></person-group><article-title>Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>33132</fpage><lpage>33140</lpage><pub-id pub-id-type="pmid">16043491</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M500608200</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>YF</given-names></name><name><surname>Soung</surname><given-names>DY</given-names></name><name><surname>Schwarz</surname><given-names>EM</given-names></name><name><surname>O'Keefe</surname><given-names>RJ</given-names></name><name><surname>Drissi</surname><given-names>H</given-names></name></person-group><article-title>Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor</article-title><source>J Cell Physiol</source><year>2006</year><volume>208</volume><fpage>77</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">16575901</pub-id><pub-id pub-id-type="doi">10.1002/jcp.20656</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>TP</given-names></name><name><surname>Spater</surname><given-names>D</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Birchmeier</surname><given-names>W</given-names></name><name><surname>Hartmann</surname><given-names>C</given-names></name></person-group><article-title>Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes</article-title><source>Dev Cell</source><year>2005</year><volume>8</volume><fpage>727</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">15866163</pub-id><pub-id pub-id-type="doi">10.1016/j.devcel.2005.02.013</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodda</surname><given-names>SJ</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name></person-group><article-title>Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors</article-title><source>Development</source><year>2006</year><volume>133</volume><fpage>3231</fpage><lpage>3244</lpage><pub-id pub-id-type="pmid">16854976</pub-id><pub-id pub-id-type="doi">10.1242/dev.02480</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holmen</surname><given-names>SL</given-names></name><name><surname>Zylstra</surname><given-names>CR</given-names></name><name><surname>Mukherjee</surname><given-names>A</given-names></name><name><surname>Sigler</surname><given-names>RE</given-names></name><name><surname>Faugere</surname><given-names>MC</given-names></name><name><surname>Bouxsein</surname><given-names>ML</given-names></name><name><surname>Deng</surname><given-names>L</given-names></name><name><surname>Clemens</surname><given-names>TL</given-names></name><name><surname>Williams</surname><given-names>BO</given-names></name></person-group><article-title>Essential role of beta-catenin in postnatal bone acquisition</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>21162</fpage><lpage>21168</lpage><pub-id pub-id-type="pmid">15802266</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M501900200</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fodde</surname><given-names>R</given-names></name></person-group><article-title>The multiple functions of tumour suppressors: it's all in APC</article-title><source>Nat Cell Biol</source><year>2003</year><volume>5</volume><fpage>190</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">12646874</pub-id><pub-id pub-id-type="doi">10.1038/ncb0303-190</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korinek</surname><given-names>V</given-names></name><name><surname>Barker</surname><given-names>N</given-names></name><name><surname>Morin</surname><given-names>PJ</given-names></name><name><surname>van Wichen</surname><given-names>D</given-names></name><name><surname>de Weger</surname><given-names>R</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><article-title>Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma</article-title><source>Science</source><year>1997</year><volume>275</volume><fpage>1784</fpage><lpage>1787</lpage><pub-id pub-id-type="pmid">9065401</pub-id><pub-id pub-id-type="doi">10.1126/science.275.5307.1784</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morin</surname><given-names>PJ</given-names></name><name><surname>Sparks</surname><given-names>AB</given-names></name><name><surname>Korinek</surname><given-names>V</given-names></name><name><surname>Barker</surname><given-names>N</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name></person-group><article-title>Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC</article-title><source>Science</source><year>1997</year><volume>275</volume><fpage>1787</fpage><lpage>1790</lpage><pub-id pub-id-type="pmid">9065402</pub-id><pub-id pub-id-type="doi">10.1126/science.275.5307.1787</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smits</surname><given-names>R</given-names></name><name><surname>Houven van Oordt</surname><given-names>W van der</given-names></name><name><surname>Luz</surname><given-names>A</given-names></name><name><surname>Zurcher</surname><given-names>C</given-names></name><name><surname>Jagmohan-Changur</surname><given-names>S</given-names></name><name><surname>Breukel</surname><given-names>C</given-names></name><name><surname>Khan</surname><given-names>PM</given-names></name><name><surname>Fodde</surname><given-names>R</given-names></name></person-group><article-title>Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts</article-title><source>Gastroenterology</source><year>1998</year><volume>114</volume><fpage>275</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">9453487</pub-id><pub-id pub-id-type="doi">10.1016/S0016-5085(98)70478-0</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bertario</surname><given-names>L</given-names></name><name><surname>Russo</surname><given-names>A</given-names></name><name><surname>Sala</surname><given-names>P</given-names></name><name><surname>Varesco</surname><given-names>L</given-names></name><name><surname>Giarola</surname><given-names>M</given-names></name><name><surname>Mondini</surname><given-names>P</given-names></name><name><surname>Pierotti</surname><given-names>M</given-names></name><name><surname>Spinelli</surname><given-names>P</given-names></name><name><surname>Radice</surname><given-names>P</given-names></name></person-group><article-title>Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis</article-title><source>J Clin Oncol</source><year>2003</year><volume>21</volume><fpage>1698</fpage><lpage>1707</lpage><pub-id pub-id-type="pmid">12721244</pub-id><pub-id pub-id-type="doi">10.1200/JCO.2003.09.118</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fodde</surname><given-names>R</given-names></name><name><surname>Edelmann</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>van Leeuwen</surname><given-names>C</given-names></name><name><surname>Carlson</surname><given-names>C</given-names></name><name><surname>Renault</surname><given-names>B</given-names></name><name><surname>Breukel</surname><given-names>C</given-names></name><name><surname>Alt</surname><given-names>E</given-names></name><name><surname>Lipkin</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>PM</given-names></name></person-group><article-title>A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors</article-title><source>Proc Natl Acad Sci USA</source><year>1994</year><volume>91</volume><fpage>8969</fpage><lpage>8973</lpage><pub-id pub-id-type="pmid">8090754</pub-id><pub-id pub-id-type="doi">10.1073/pnas.91.19.8969</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>AR</given-names></name><name><surname>Shoemaker</surname><given-names>AR</given-names></name><name><surname>Connelly</surname><given-names>CS</given-names></name><name><surname>Clipson</surname><given-names>L</given-names></name><name><surname>Gould</surname><given-names>KA</given-names></name><name><surname>Luongo</surname><given-names>C</given-names></name><name><surname>Dove</surname><given-names>WF</given-names></name><name><surname>Siggers</surname><given-names>PH</given-names></name><name><surname>Gardner</surname><given-names>RL</given-names></name></person-group><article-title>Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation</article-title><source>Dev Dyn</source><year>1995</year><volume>203</volume><fpage>422</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">7496034</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kielman</surname><given-names>MF</given-names></name><name><surname>Rindapaa</surname><given-names>M</given-names></name><name><surname>Gaspar</surname><given-names>C</given-names></name><name><surname>van Poppel</surname><given-names>N</given-names></name><name><surname>Breukel</surname><given-names>C</given-names></name><name><surname>van Leeuwen</surname><given-names>S</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Roberts</surname><given-names>S</given-names></name><name><surname>Smits</surname><given-names>R</given-names></name><name><surname>Fodde</surname><given-names>R</given-names></name></person-group><article-title>Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling</article-title><source>Nat Genet</source><year>2002</year><volume>32</volume><fpage>594</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">12426568</pub-id><pub-id pub-id-type="doi">10.1038/ng1045</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fodde</surname><given-names>R</given-names></name><name><surname>Smits</surname><given-names>R</given-names></name></person-group><article-title>Cancer biology. A matter of dosage</article-title><source>Science</source><year>2002</year><volume>298</volume><fpage>761</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">12399571</pub-id><pub-id pub-id-type="doi">10.1126/science.1077707</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schipani</surname><given-names>E</given-names></name><name><surname>Ryan</surname><given-names>HE</given-names></name><name><surname>Didrickson</surname><given-names>S</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Knight</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>RS</given-names></name></person-group><article-title>Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival</article-title><source>Genes Dev</source><year>2001</year><volume>15</volume><fpage>2865</fpage><lpage>2876</lpage><pub-id pub-id-type="pmid">11691837</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>Fujiwara</surname><given-names>Y</given-names></name><name><surname>Orkin</surname><given-names>SH</given-names></name></person-group><article-title>Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>5037</fpage><lpage>5042</lpage><pub-id pub-id-type="pmid">10220414</pub-id><pub-id pub-id-type="doi">10.1073/pnas.96.9.5037</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheah</surname><given-names>KS</given-names></name><name><surname>Lau</surname><given-names>ET</given-names></name><name><surname>Au</surname><given-names>PK</given-names></name><name><surname>Tam</surname><given-names>PP</given-names></name></person-group><article-title>Expression of the mouse alpha 1(II) collagen gene is not restricted to cartilage during development</article-title><source>Development</source><year>1991</year><volume>111</volume><fpage>945</fpage><lpage>953</lpage><pub-id pub-id-type="pmid">1879363</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>F</given-names></name><name><surname>Chung</surname><given-names>UI</given-names></name><name><surname>Ohba</surname><given-names>S</given-names></name><name><surname>McMahon</surname><given-names>J</given-names></name><name><surname>Kronenberg</surname><given-names>HM</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name></person-group><article-title>Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>1309</fpage><lpage>1318</lpage><pub-id pub-id-type="pmid">14973297</pub-id><pub-id pub-id-type="doi">10.1242/dev.01006</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christ</surname><given-names>B</given-names></name><name><surname>Wilting</surname><given-names>J</given-names></name></person-group><article-title>From somites to vertebral column</article-title><source>Ann Anat</source><year>1992</year><volume>174</volume><fpage>23</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">1605355</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aoyama</surname><given-names>H</given-names></name><name><surname>Mizutani-koseki</surname><given-names>S</given-names></name><name><surname>Koseki</surname><given-names>H</given-names></name></person-group><article-title>Three developmental compartments involved in rib formation</article-title><source>Int J Dev Biol</source><year>2005</year><volume>49</volume><fpage>325</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">15906248</pub-id><pub-id pub-id-type="doi">10.1387/ijdb.041932ha</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wealthall</surname><given-names>RJ</given-names></name><name><surname>Herring</surname><given-names>SW</given-names></name></person-group><article-title>Endochondral ossification of the mouse nasal septum</article-title><source>Anat Rec A Discov Mol Cell Evol Biol</source><year>2006</year><volume>288</volume><fpage>1163</fpage><lpage>1172</lpage><pub-id pub-id-type="pmid">17031811</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>GJ</given-names></name><name><surname>Lucas</surname><given-names>VS</given-names></name></person-group><article-title>Growth of the nasal septum in the Snell strain of hypopituitary dwarf mouse</article-title><source>Eur J Orthod</source><year>1994</year><volume>16</volume><fpage>138</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">8005201</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Hilton</surname><given-names>MJ</given-names></name><name><surname>Tu</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name><name><surname>Long</surname><given-names>F</given-names></name></person-group><article-title>Sequential roles of Hedgehog and Wnt signaling in osteoblast development</article-title><source>Development</source><year>2005</year><volume>132</volume><fpage>49</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">15576404</pub-id><pub-id pub-id-type="doi">10.1242/dev.01564</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tamamura</surname><given-names>Y</given-names></name><name><surname>Otani</surname><given-names>T</given-names></name><name><surname>Kanatani</surname><given-names>N</given-names></name><name><surname>Koyama</surname><given-names>E</given-names></name><name><surname>Kitagaki</surname><given-names>J</given-names></name><name><surname>Komori</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Costantini</surname><given-names>F</given-names></name><name><surname>Wakisaka</surname><given-names>S</given-names></name><name><surname>Pacifici</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>19185</fpage><lpage>19195</lpage><pub-id pub-id-type="pmid">15760903</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M414275200</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>AR</given-names></name><name><surname>Pitot</surname><given-names>HC</given-names></name><name><surname>Dove</surname><given-names>WF</given-names></name></person-group><article-title>A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse</article-title><source>Science</source><year>1990</year><volume>247</volume><fpage>322</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">2296722</pub-id><pub-id pub-id-type="doi">10.1126/science.2296722</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hartmann</surname><given-names>C</given-names></name></person-group><article-title>A Wnt canon orchestrating osteoblastogenesis</article-title><source>Trends Cell Biol</source><year>2006</year><volume>16</volume><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">16466918</pub-id><pub-id pub-id-type="doi">10.1016/j.tcb.2006.01.001</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>MS</given-names></name><name><surname>Levasseur</surname><given-names>R</given-names></name><name><surname>Lobov</surname><given-names>I</given-names></name><name><surname>Chang</surname><given-names>BH</given-names></name><name><surname>Glass</surname><given-names>DA</given-names></name><name><surname>Hartmann</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Hwang</surname><given-names>TH</given-names></name><name><surname>Brayton</surname><given-names>CF</given-names></name><etal></etal></person-group><article-title>Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor</article-title><source>J Cell Biol</source><year>2002</year><volume>157</volume><fpage>303</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">11956231</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200201089</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bodine</surname><given-names>PV</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Kharode</surname><given-names>YP</given-names></name><name><surname>Bex</surname><given-names>FJ</given-names></name><name><surname>Lambert</surname><given-names>AJ</given-names></name><name><surname>Goad</surname><given-names>MB</given-names></name><name><surname>Gaur</surname><given-names>T</given-names></name><name><surname>Stein</surname><given-names>GS</given-names></name><name><surname>Lian</surname><given-names>JB</given-names></name><name><surname>Komm</surname><given-names>BS</given-names></name></person-group><article-title>The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice</article-title><source>Mol Endocrinol</source><year>2004</year><volume>18</volume><fpage>1222</fpage><lpage>1237</lpage><pub-id pub-id-type="pmid">14976225</pub-id><pub-id pub-id-type="doi">10.1210/me.2003-0498</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>CN</given-names></name><name><surname>Longo</surname><given-names>KA</given-names></name><name><surname>Wright</surname><given-names>WS</given-names></name><name><surname>Suva</surname><given-names>LJ</given-names></name><name><surname>Lane</surname><given-names>TF</given-names></name><name><surname>Hankenson</surname><given-names>KD</given-names></name><name><surname>Macdougald</surname><given-names>OA</given-names></name></person-group><article-title>Regulation of osteoblastogenesis and bone mass by Wnt10b</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>3324</fpage><lpage>3329</lpage><pub-id pub-id-type="pmid">15728361</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0408742102</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glass</surname><given-names>DA</given-names></name><name><surname>Bialek</surname><given-names>P</given-names></name><name><surname>Ahn</surname><given-names>JD</given-names></name><name><surname>Starbuck</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>MS</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Long</surname><given-names>F</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name><name><surname>Lang</surname><given-names>RA</given-names></name><etal></etal></person-group><article-title>Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation</article-title><source>Dev Cell</source><year>2005</year><volume>8</volume><fpage>751</fpage><lpage>764</lpage><pub-id pub-id-type="pmid">15866165</pub-id><pub-id pub-id-type="doi">10.1016/j.devcel.2005.02.017</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yuasa</surname><given-names>T</given-names></name><name><surname>Otani</surname><given-names>T</given-names></name><name><surname>Koike</surname><given-names>T</given-names></name><name><surname>Iwamoto</surname><given-names>M</given-names></name><name><surname>Enomoto-Iwamoto</surname><given-names>M</given-names></name></person-group><article-title>Wnt/beta-catenin signaling stimulates matrix catabolic genes and activity in articular chondrocytes: its possible role in joint degeneration</article-title><source>Lab Invest</source><year>2008</year><volume>88</volume><fpage>264</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">18227807</pub-id><pub-id pub-id-type="doi">10.1038/labinvest.3700747</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Enomoto-Iwamoto</surname><given-names>M</given-names></name><name><surname>Otani</surname><given-names>T</given-names></name><name><surname>Koike</surname><given-names>T</given-names></name><name><surname>Iwamoto</surname><given-names>M</given-names></name></person-group><article-title>Wnt/&#x003b2;-Catenin Signaling in Chondrocyte Function and Cartilage Matrix Disruption</article-title><source>Current rheumatology reviews</source><year>2006</year><volume>2</volume><fpage>31</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.2174/157339706775697035</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Tang</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>C</given-names></name><name><surname>Rosier</surname><given-names>RN</given-names></name><name><surname>O'Keefe</surname><given-names>RJ</given-names></name><name><surname>Zuscik</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name></person-group><article-title>Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice</article-title><source>J Bone Miner Res</source><year>2009</year><volume>24</volume><fpage>12</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">18767925</pub-id><pub-id pub-id-type="doi">10.1359/jbmr.080901</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Oh</surname><given-names>CD</given-names></name><name><surname>Hwang</surname><given-names>SG</given-names></name><name><surname>Chun</surname><given-names>CH</given-names></name><name><surname>Oh</surname><given-names>SH</given-names></name><name><surname>Seong</surname><given-names>JK</given-names></name><name><surname>Huh</surname><given-names>TL</given-names></name><name><surname>Chun</surname><given-names>JS</given-names></name></person-group><article-title>Regulation of the chondrocyte phenotype by beta-catenin</article-title><source>Development</source><year>2002</year><volume>129</volume><fpage>5541</fpage><lpage>5550</lpage><pub-id pub-id-type="pmid">12403723</pub-id><pub-id pub-id-type="doi">10.1242/dev.00110</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McLeod</surname><given-names>MJ</given-names></name></person-group><article-title>Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S</article-title><source>Teratology</source><year>1980</year><volume>22</volume><fpage>299</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">6165088</pub-id><pub-id pub-id-type="doi">10.1002/tera.1420220306</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clement-Lacroix</surname><given-names>P</given-names></name><name><surname>Ai</surname><given-names>M</given-names></name><name><surname>Morvan</surname><given-names>F</given-names></name><name><surname>Roman-Roman</surname><given-names>S</given-names></name><name><surname>Vayssiere</surname><given-names>B</given-names></name><name><surname>Belleville</surname><given-names>C</given-names></name><name><surname>Estrera</surname><given-names>K</given-names></name><name><surname>Warman</surname><given-names>ML</given-names></name><name><surname>Baron</surname><given-names>R</given-names></name><name><surname>Rawadi</surname><given-names>G</given-names></name></person-group><article-title>Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>17406</fpage><lpage>17411</lpage><pub-id pub-id-type="pmid">16293698</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0505259102</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dannenberg</surname><given-names>JH</given-names></name><name><surname>Schuijff</surname><given-names>L</given-names></name><name><surname>Dekker</surname><given-names>M</given-names></name><name><surname>van der Valk</surname><given-names>M</given-names></name><name><surname>te Riele</surname><given-names>H</given-names></name></person-group><article-title>Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130</article-title><source>Genes Dev</source><year>2004</year><volume>18</volume><fpage>2952</fpage><lpage>2962</lpage><pub-id pub-id-type="pmid">15574596</pub-id><pub-id pub-id-type="doi">10.1101/gad.322004</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eerden</surname><given-names>BC van der</given-names></name><name><surname>van Til</surname><given-names>NP</given-names></name><name><surname>Brinkmann</surname><given-names>AO</given-names></name><name><surname>Lowik</surname><given-names>CW</given-names></name><name><surname>Wit</surname><given-names>JM</given-names></name><name><surname>Karperien</surname><given-names>M</given-names></name></person-group><article-title>Gender differences in expression of androgen receptor in tibial growth plate and metaphyseal bone of the rat</article-title><source>Bone</source><year>2002</year><volume>30</volume><fpage>891</fpage><lpage>896</lpage><pub-id pub-id-type="pmid">12052459</pub-id><pub-id pub-id-type="doi">10.1016/S8756-3282(02)00723-8</pub-id></citation></ref></ref-list></back></article> 